Paper Details

  1. Home
  2. Paper Details

Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.

Author: CelikTuba, KoskerMustafa

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This report presents a case of erlotinib-induced eyelash trichomegaly and other ocular side effects in a patient with metastatic lung adenocarcinoma. Erlotinib is an epidermal growth factor inhibitor used to treat certain cancers. The report highlights the importance of recognizing this rare side effect to prevent complications, such as corneal ulcers.
Paper Details　
Original Abstract of the Article :
Therapeutics belonging to the group of epidermal growth factor inhibitors are currently in widespread use for the treatment of certain malignancies, especially in advanced non-small cell lung cancer. A wide spectrum of the cutaneous side effects of these drugs are well known but the ocular side effe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.clae.2014.08.005

データ提供：米国国立医学図書館（NLM）

Ocular Side Effects of Erlotinib

This research takes a closer look at the world of cancer treatments, where the goal is to conquer a formidable opponent. This study examines the potential side effects of erlotinib, a medication used to treat certain cancers, specifically focusing on its impact on the eyes. It's like observing the landscape of a desert battleground, carefully assessing the potential collateral damage.

Erlotinib Can Cause Eyelash Growth

The researchers found that erlotinib, while effective in fighting cancer, can also cause eyelashes to grow excessively. This is like a desert oasis unexpectedly blooming with a wild and untamed garden. The study also noted that this eyelash growth can lead to eye irritation and corneal damage, highlighting the importance of monitoring for these potential side effects.

Navigating the Desert of Cancer Treatment

This research highlights the importance of understanding the potential side effects of cancer treatments. While erlotinib offers a valuable tool for fighting cancer, it's important to be aware of its potential impact on the eyes and seek prompt medical attention if any concerns arise. It's like having a guide to help navigate the desert of cancer treatment, ensuring a safe and effective journey.

Dr. Camel's Conclusion

This research delves into the intricate world of cancer treatment, a challenging journey through a desert of uncertainty. The study sheds light on a unique side effect of erlotinib, emphasizing the importance of recognizing and managing these potential complications for a smoother and more successful battle against cancer.
Date :
  1. Date Completed 2015-10-15
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25249292

DOI: Digital Object Identifier

10.1016/j.clae.2014.08.005

Related Literature

Article Analysis
・Side Effects of erlotinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.